Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Recurrent VTE in relation to presence or absence of anticoagulant therapy

From: Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis

  CVC-VTE Non-CVC-VTE
N = 227 N = 119
During anticoagulation, n/N (%) 6/199 (3.0) 2/110 (1.8)
Following discontinuation of anticoagulants, n/N (%) 8/199 (4.0) 1/110 (0.9)
No anticoagulant group, n/N (%) 4/28 (14.3) 0/9 (0)